Decrease (-) Restore Default Increase (+)

Clinical Trials

Topic   Urology
Title   Metformin Prostate Cancer Adjuvant Trial
Summary   NYU Winthrop Hospital Department of Urology is conducting this clinical research study for men ages 18 or older who have biopsy proven prostate cancer and have been treated with either radiation therapy or surgery, who have indicators of high-risk disease, or who have a rising prostate specific antigen after treatment.
Description   This study will examine the effect that metformin hydrochloride has on prostate specific antigen levels in men with prostate cancer.
IRB Number   14015
Inclusion/Notes   To be eligible for this clinical research study you must:

- Be 18 years old
- Be diagnosed with prostate cancer
- Have been treated with radiation therapy or surgery
- Not have evidence of metastatic prostate cancer or a diagnosis of type 1 diabetes
Principal Name   Aaron Katz, MD
Contact Name   Kaitlin Kosinski, MS
Phone   516-535-1900